Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zivo Bioscience (ZIVO)

Zivo Bioscience (ZIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
ZIVO Bioscience CEO Letter to Shareholders Highlights Progress with Human Nutrition and Animal Therapeutic Businesses

ZIVO Bioscience, Inc. (OTCQB: ZIVO) , a biotech and agtech R&D company engaged in the development of therapeutic and nutritional products derived from proprietary algal cultures, today issued the...

ZIVO : 9.3500 (-13.02%)
ZIVO Bioscience Receives $1 Million Bridge Financing

Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”) , a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary...

ZIVO : 9.3500 (-13.02%)
Stocks Set To Open Higher As Investors Await U.S. Inflation Data

March S&P 500 futures (ESH23) are trending up +0.06%, and March Nasdaq 100 E-Mini futures (NQH23) are up +0.37% this morning as investors look ahead to crucial U.S. inflation data due this week for more...

DE : 565.73 (-0.27%)
SMIN.LN : 2,548.000 (+0.24%)
ZIVO : 9.3500 (-13.02%)
CSCO : 82.36 (+1.48%)
KO : 78.51 (+1.50%)
ESH23 : 3,957.05s (-0.09%)
NQH26 : 24,567.25 (-0.34%)
PGRE : 6.60 (+0.15%)
OCUL : 8.91 (+4.21%)
FIS : 50.82 (-1.45%)
APRN : 12.99 (-0.08%)
CAT : 678.31 (-1.95%)
ZIVO Bioscience Announces Results of Study with its Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens

Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”) , a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary...

ZIVO : 9.3500 (-13.02%)
ZIVO Bioscience Announces Plans for a New Streamlined, Focused Corporate Structure and Establishes the ZIVOLife Agtech Business

Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary...

ZIVO : 9.3500 (-13.02%)
ZIVO Bioscience CEO Issues Letter to Shareholders

Zivo Bioscience, Inc. (NASDAQ: ZIVO), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today...

ZIVO : 9.3500 (-13.02%)
ZIVO Reports that USDA Claims Regulatory Jurisdiction for New Coccidiosis Treatment

ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary...

ZIVO : 9.3500 (-13.02%)
Zivo Bioscience Joins Russell Microcap® Index

ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”) , a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary...

ZIVO : 9.3500 (-13.02%)
Zivo Bioscience Joins Russell Microcap® Index

ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”) , a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary...

ZIVO : 9.3500 (-13.02%)
Zivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from Nasdaq

ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal...

ZIVO : 9.3500 (-13.02%)

Barchart Exclusives

1 Dividend Stock to Buy Now as Trump Tackles Housing Affordability
Trump’s push to lower mortgage rates, cap card interest, and curb institutional home buying puts dividend‑payer Lennar at the center of the housing‑affordability trade, with the stock still trading at a modest discount. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar